These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8510700)
1. The end stage renal disease program. Robertson JS; Graves J N Engl J Med; 1993 Jul; 329(2):139; author reply 140-1. PubMed ID: 8510700 [No Abstract] [Full Text] [Related]
2. The American health care system. The End Stage Renal Disease Program. Iglehart JK N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833 [No Abstract] [Full Text] [Related]
3. Should we limit participation in the ESRD Program? Sullivan JD; McGue WF Nephrol News Issues; 2012 Jun; 26(7):28, 30-2. PubMed ID: 22928242 [No Abstract] [Full Text] [Related]
4. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Prodjosudjadi W Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003 [TBL] [Abstract][Full Text] [Related]
5. The organization of medical care. Lessons from the Medicare end stage renal disease program. Levinsky NG N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437 [No Abstract] [Full Text] [Related]
6. Comparison of treatment costs between dialysis and transplantation. Eggers P Semin Nephrol; 1992 May; 12(3):284-9. PubMed ID: 1615249 [No Abstract] [Full Text] [Related]
7. End stage renal disease--the end of the road. Rao M Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587 [No Abstract] [Full Text] [Related]
8. Illegal immigration. The impact on renal care. Chartier K Nephrol News Issues; 2004 Dec; 18(13):27-8, 30, 32. PubMed ID: 15643821 [No Abstract] [Full Text] [Related]
9. Cost functions for dialysis facilities and the quality of dialysis. Escarce JJ; Feldman HI Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497 [No Abstract] [Full Text] [Related]
10. Is case-mix adjustment necessary for an expanded dialysis bundle? Hirth RA; Wolfe RA; Wheeler JR; Roys EC; Tedeschi PJ; Pozniak AS; Wright GT Health Care Financ Rev; 2003; 24(4):77-88. PubMed ID: 14628401 [TBL] [Abstract][Full Text] [Related]
11. Dialysis and Total Health Care Costs in the United States and Worldwide: The Financial Impact of a Single-Payer Dominant System in the US. Pockros BM; Finch DJ; Weiner DE J Am Soc Nephrol; 2021 Sep; 32(9):2137-2139. PubMed ID: 34362835 [TBL] [Abstract][Full Text] [Related]
15. The organization and financing of kidney dialysis and transplant care in the United States of America. Hirth RA Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296 [TBL] [Abstract][Full Text] [Related]
16. Conditions for coverage fail to relieve administrative burden. Wish D Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648 [No Abstract] [Full Text] [Related]
17. Establishing and controlling chronic renal failure treatment costs. A pressing need. Martín Hernández R Nefrologia; 2011; 31(3):256-9. PubMed ID: 21629334 [No Abstract] [Full Text] [Related]
18. The 2011 ESRD prospective payment system: welcome to the bundle. Weiner DE Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431 [No Abstract] [Full Text] [Related]
19. Adapting to changes in Medicare cost report requirements. Rossi T Nephrol News Issues; 2005 Sep; 19(10):36-9. PubMed ID: 16187645 [No Abstract] [Full Text] [Related]
20. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries. Cantaluppi A; East P J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]